ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease
Gastroesophageal reflux disease (GERD) continues to be among the most common
diseases seen by gastroenterologists, surgeons, and primary care physicians. Our …
diseases seen by gastroenterologists, surgeons, and primary care physicians. Our …
The risks of long-term use of proton pump inhibitors: a critical review
M Jaynes, AB Kumar - Therapeutic advances in drug safety, 2019 - journals.sagepub.com
Proton pump inhibitors (PPIs) are among the most frequently prescribed medications. Their
use is likely even higher than estimated due to an increase in the number of PPIs available …
use is likely even higher than estimated due to an increase in the number of PPIs available …
[HTML][HTML] Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis
A Trifan, C Stanciu, I Girleanu, OC Stoica… - World journal of …, 2017 - ncbi.nlm.nih.gov
AIM To perform a systematic review and meta-analysis on proton pump inhibitors (PPIs)
therapy and the risk of Clostridium difficile infection (CDI). METHODS We conducted a …
therapy and the risk of Clostridium difficile infection (CDI). METHODS We conducted a …
Guidelines for diagnosis, treatment, and prevention ofclostridium difficileInfections
CM Surawicz, LJ Brandt, DG Binion… - Official journal of the …, 2013 - journals.lww.com
Clostridium difficileinfection (CDI) is a leading cause of hospital-associated gastrointestinal
illness and places a high burden on our health-care system. Patients with CDI typically have …
illness and places a high burden on our health-care system. Patients with CDI typically have …
[HTML][HTML] Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015
K Iwakiri, Y Kinoshita, Y Habu, T Oshima… - Journal of …, 2016 - Springer
As an increase in gastroesophageal reflux disease (GERD) has been reported in Japan,
and public interest in GERD has been increasing, the Japanese Society of Gastroenterology …
and public interest in GERD has been increasing, the Japanese Society of Gastroenterology …
Risk ofClostridium difficileInfection with acid suppressing drugs and antibiotics: Meta-analysis
OBJECTIVES: Several studies have raised concern regarding the possible association
between proton-pump inhibitors (PPIs) andClostridium difficileinfection (CDI). We aimed to …
between proton-pump inhibitors (PPIs) andClostridium difficileinfection (CDI). We aimed to …
Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence
ML Maes, DR Fixen… - Therapeutic advances in …, 2017 - journals.sagepub.com
Proton-pump inhibitors (PPIs) are a widely prescribed class of medications used to treat acid-
related disorders and use has significantly increased over the last few decades. PPIs are …
related disorders and use has significantly increased over the last few decades. PPIs are …
Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011
AS Chitnis, SM Holzbauer, RM Belflower… - JAMA internal …, 2013 - jamanetwork.com
Importance Clostridium difficileinfection (CDI) has been increasingly reported among
healthy individuals in the community. Recent data suggest that community-associated CDI …
healthy individuals in the community. Recent data suggest that community-associated CDI …
[HTML][HTML] Risk factors for Clostridium difficile infections–an overview of the evidence base and challenges in data synthesis
P Eze, E Balsells, MH Kyaw, H Nair - Journal of global health, 2017 - ncbi.nlm.nih.gov
Background Recognition of a broad spectrum of disease and development of Clostridium
difficile infection (CDI) and recurrent CDI (rCDI) in populations previously considered to be …
difficile infection (CDI) and recurrent CDI (rCDI) in populations previously considered to be …
Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile infection
EG McDonald, J Milligan, C Frenette… - JAMA internal …, 2015 - jamanetwork.com
Importance Clostridium difficileinfection (CDI) is associated with significant morbidity,
mortality, and a high risk of recurrence. Proton pump inhibitor (PPI) use is associated with an …
mortality, and a high risk of recurrence. Proton pump inhibitor (PPI) use is associated with an …